30.2 C
Vientiane
Monday, September 15, 2025
spot_img

Cision PR Newswire

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225). The trial will evaluate cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific antibody, in combination with lenvatinib versus lenvatinib alone...

Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs

TOKYO, Aug. 28, 2025 /PRNewswire/ -- Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived...

GoChengdu: Together at TWG 2025: Young Athletes Weaving a Global Tale of Friendship

CHENGDU, China, Aug. 28, 2025 /PRNewswire/ -- On the evening of August 17, The World Games 2025 Chengdu (TWG 2025) concluded successfully at the...

SIHL Remains High Dividend Policy with a Payout Ratio of 43.8%

Sustained Breakthroughs in The Green and Health Business   With Approximately HK$4 Billion in cash Recovered from the Successful Privatization of Canvest Environmental ...

SF Holding Reports Solid First Half 2025 Results, Demonstrating Logistics Leadership in Asia

Daily parcel volume reached 43.4 million for First Half 2025, 26.4% increase year-on-year, outpacing industry average growth; Revenue reached...

ECOVACS 2024 Sustainability Report Highlights Its Commitment to Sustainability and Data Security

SUZHOU, China, Aug. 28, 2025 /PRNewswire/ -- Recently, ECOVACS (603486.SH), a global leader in service robotics, has outlined its environmental, social and governance performance...